CONTRAFECT CORP
Profile
Company Names
CONTRAFECT CORP
Addresses
28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY 10701
28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY 10701
469 SEVENTH AVENUE, 3RD FLOOR, NEW YORK, NY 10018
Phone Numbers
914-207-2300
212-359-9553
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2008
State Incorporated:
DELAWARE
Total Amount Raised:
$48,793,158.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2015-06-12
$20,000,000.00
$20,000,000.00
$0.00
Equity
4
2014-02-24
$0.00
INDEFINITE
INDEFINITE
Equity
3
2013-06-18
$11,963,650.00
$15,000,000.00
$3,036,350.00
Debt
2
2011-08-31
$12,502,905.00
$25,000,000.00
$12,497,095.00
Equity
1
2010-08-06
$4,326,603.00
$10,000,000.00
$5,673,397.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN
ABELES
DIRECTOR
SOL
BARER
DIRECTOR
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
JULIA
P.
GREGORY
EXECUTIVE OFFICER, DIRECTOR
CARY
SUCOFF
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-02-24
